Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

Tue, 26th Oct 2021 19:06

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Yellow Cake PLC - Jersey-based investor in uranium - Plans to raise USD150 million through placing. Will fund purchase of three millions pounds of physical uranium. "The long term outlook for the uranium price remains strong, driven by the more positive demand outlook and on-going supply constraints, causing the supply deficit to grow every year. We continue to seek further opportunities for value accretive opportunistic uranium purchases at an attractive price," Chief Executive Officer Andre Liebenberg says.

----------

Mercia Asset Management PLC - West Midlands-based asset manager - Completes GBP1.8 million investment into new portfolio company Forensic Analytics Ltd, alongside GBP2.7 million backing by Mercia managed Northern VCTs. "Following this investment, Mercia holds an 8.9% fully diluted direct equity stake in Forensic Analytics, with the Northern VCTs holding a further 13.9% fully diluted equity stake," Mercia says.

----------

Tern PLC - investor focused on the internet of things - Says "significant business momentum" continues across principal portfolio firms. Device Authority Ltd investee launches KeyScaler Edge offering to address IoT security challenges. "In addition to new customer wins and repeat orders, Device Authority have recently entered into further distribution partnerships, including with Trusted Objects, a leading independent player in cybersecurity technologies for embedded systems and cloud device management platforms, and with Titan Automotive Solutions, a leading provider of car connectivity solutions with a global presence," Tern says. Tern owns 57% of Device Authority. Virtual reality focused investee FVRVS Ltd, meanwhile, wins deal with company previously using a competitor's product. InVMA Ltd sees "strong sales growth", while Wyld Networks AB "continued to make further significant progress following its IPO on the NASDAQ First North Growth Market in Stockholm".

----------

Path Investments PLC - Bingley, England-based natural resources investment company - Says longstop date for DG Innovate Ltd buy extended to December 31. "Path and its advisers continue to progress the proposed transaction," company says.

----------

Caerus Mineral Resources PLC - London-based exploration & resource development company - Says trenching of stockpiles at Troulli project finds "very high-grade visible copper mineralisation". Copper grades are "highly significant", based on semi-quantitative XRF analysis. "Samples have been collected and are ready for dispatch to the assay laboratory," Caerus says. Duplicate samples also sent to partner Jubilee Metals Group PLC for testwork.

----------

Petra Diamonds Ltd - London-based diamond miner - Says revenue in first quarter ended September 30 improves year-on-year to USD114.9 million from USD77.7 million a year earlier. Says output falls annually to 861,991 carats from 974,346 carats.

----------

IMC Exploration Group PLC - Dublin-based exploration company focused on Ireland - Says drillhole 21-3850-01 at West Avoca encounters "four zones of massive and semi massive sulphide mineralisation". Says 18.7 metre interval or zinc, lead and silver mineralisation found. "IMC plans that the drill programme will allow an independent resource calculation to be undertaken in addition to that already in place for the spoils' and tailings' project," IMC adds.

----------

Angus Energy PLC - oil & gas development company - Shares revised competent persons report at Saltfleetby gas field. Says conservative estimate, or P90, of future cashflows to Angus stands at GBP31.7 million. Mid-case, or P50, has it at GBP55.9 million. Angus adds: "In summary the report estimates production giving rise to gross field revenues, before costs on a mid-case basis of GBP230 million (previously GBP141 million) of which Angus's share is 51%."

----------

Oxford Metrics PLC - software company servicing infrastructure, life sciences, entertainment and engineering markets - Says motion measurement unit Vicon wins deal with volumetric content and virtual production firm Dimension Studios. "Vicon's tracking, of both rigid and full body subjects, will be used alongside Dimension Studio's volumetric and real-time development capabilities by leading visual effects company DNEG for several high-profile virtual production projects - including a major motion picture and a 10-hour TV series," Oxford Metrics says.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says third quarter sales "strong" at USD964,000. "Importantly, both the September and June 2021 quarters combined have delivered a record USD2.24 million in cash receipts from customers over the 6-month period, with increasing month on month sales generated from new key markets, such as the UK and Ireland," MGC adds.

----------

ReNeuron Group PLC - Bridgend, Wales-based exosome therapeutics company - Teams with University College London to research generation of immune cells from induced pluripotent stem cells as a potential cancer therapy. ReNeuron will provide UCL with the stem cells. Company adds: "Induced pluripotent stem cells can differentiate into any cell type found in the body, but unlike most iPSCs, ReNeuron's proprietary CTX-iPSCs carry the conditional immortalisation system incorporated into CTX. ReNeuron's CTX derived iPSC's are available as clinical grade material potentially allowing faster development of arising therapeutics and the company believes that its conditional immortalisation technology could allow the company to manufacture cost efficiently at scale to treat large numbers of patients providing 'off the shelf' cell therapies."

----------

Omni Egis PLC - debt financing solutions provider for small to medium-sized businesses - Says AQSE listing "not commercial for the company to raise funds at the current share price". Notes market capitalisation currently below liquid resources. Convenes general meeting on November 18 to vote on AQSE withdrawal.

----------

CATCo Reinsurance Opportunities Fund Ltd - invests in catastrophe reinsurance risks - Receives "substantial level of investor support" for Markel CATCo Investment Management Ltd-funded buyout. Markel is CATCo's manager.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Jul 2010 07:27

ReNeuron Group To Present New Data Of Lead CTX Stem Cell Line

LONDON (Dow Jones)--ReNeuron Group PLC (RENE.LN), a clinical-stage stem cell business, said Monday it will present important new data regarding the mechanisms of action of its lead CTX stem cell line in pre-clinical models of brain damage. MAIN FACTS: -The results of these studies will be pr

Read more
29 Jun 2010 07:51

ReNeuron Group FY Pretax Loss GBP6.2M On Revenue GBP31,000

LONDON (Dow Jones)--ReNeuron Group PLC (RENE.LN) said Tuesday that for the year ended March 31, it made a pretax loss of GBP6.2 million on revenue of GBP31,000. MAIN FACTS: -Revenue GBP31,000 (2009: GBP93,000) -Operating loss GBP6.2 million (2009: loss GBP4.7 million) -Pretax loss GB

Read more
28 Jan 2010 13:48

Sector movers: Drug sector off colour

The pharmaceuticals sector fell back after AstraZeneca posted a 10% rise in fourth quarter earnings, but predicted 2010 revenues would be hit by the loss of exclusive rights to sell certain drugs. The company is also planning to cut 8,000 jobs from its global workforce of 63,000. While Astra falls

Read more
28 Jan 2010 11:25

Small caps round-up: Xcite, ReNeuron, CPL Resources

Shares in Xcite Energy jumped after the oil group said its subsidiary Xcite Energy Resources has concluded an agreement with BP subsidiary BP Oil International to market and sell Xcite's crude oil from the Bentley field in the North Sea. ReNeuron group climbed after the stem cell developer said Pha

Read more
11 Jan 2010 16:41

London close: Footsie gives up gains

The leading share index gave up early gains to finish only slightly higher as euphoria over strong trade figures from China in December gave way to renewed fears over recovery prospects. China's December imports jumped by 55.9% from the same month the previous year, while exports were 17.7% higher

Read more
11 Jan 2010 14:16

London afternoon: Stocks back on the climb

Leading shares, which had been surrendering early gains at the end of the morning, picked up again over the lunch time session, helped by expectations of a firm start by Wall Street. In the absence of much in the way of corporate events to attract attention, traders have been focused on broker note

Read more
11 Jan 2010 08:44

ReNeuron poised for stroke treatment trials

Stem cell therapy group ReNeuron said it is on track to start human trials of its flagship treatment ReN001 for disabled stroke patients in the first quarter of this year. ReNeuron said it has submitted extra data for the UK's Gene Therapy Advisory Committee. If a successful review of the data is r

Read more
26 Nov 2009 14:45

Small caps round-up: Hampson Industries, Bezant, Tangent Comms...

Aerospace and engineering group Hampson Industries reported a 32% slump in first half profit before tax to £11m on revenue down 12% to £97m. "Although the immediate outlook for our core markets remains uncertain, present customer indications and the scale of new work in the pipeline all point to a

Read more
16 Nov 2009 11:54

Small caps round-up: Ocean Wilsons, Fortune Oil, Freshwater...

PR and marketing group Freshwater's profits fell sharply last year, but the fourth quarter saw an improvement that has continued into the current year. Pre-tax profit fell to £0.24m from £1.17m, on sales of £9.1m down from £9.5m. "Profitability improved in the second half, and we have gone into th

Read more
2 Oct 2009 15:33

ReNeuron boosted by study findings

Shares in stem cell developer ReNeuron were wanted after the company drew attention to the publication of new research using the company's ReNcell neural stem cell products. Researchers based in California have developed a safe strategy for reprogramming cells to a pluripotent (capable of affecting

Read more
17 Sep 2009 08:39

Small caps round-up: Byotrol, ReNeuron, Accuma...

Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30 to be ahead of expectations. Shares in Meridian Petroleum gushed higher after the oil and gas firm announced an increase in prospective resources in

Read more
8 Jul 2009 13:44

Sector movers: Astra lifts drug stocks after broker boost

Pharmaceutical stocks are higher after the broker Panmure Gordon said AstraZeneca was set to benefit from US rivals that produce generic alternatives to its cancer drug Casodex being too slow off the mark. AstraZeneca's slight rise is not as impressive as that of stem cell therapy developer ReNeuro

Read more
8 Jul 2009 10:55

Small caps round-up: Brainjuicer, ReNeuron, Hamworthy...

Market researcher BrainJuicer, whose clients include Unilever and Nike, posted revenue growth of about 22% for the first half and said it expects to make further progress in 2009. Stem cell therapy developer ReNeuron said clinical data on its lead CTX neural stem cell line in stroke and neurodegene

Read more
30 Jun 2009 09:00

Small caps round-up: MediaZest, Reneuron, Atlantic Coal...

Display advertising and screens provider Mediazest's pre-tax profits slide in the year as administrative expenses were too high, prompting the firm to undertake further cost cutting measures. The group also said first half of 2009 has seen a drop in activity as a consequence of the economic downt

Read more
9 Jun 2009 12:21

Angel rallies on ReNeuron deal

Angel Biotechnology rallied on news that the biopharmaceutical contract manufacturer signed a GMP manufacturing deal with ReNeuron. The value of the contract was not disclosed. The signing of deal follows on from ReNeuron's recent MHRA regulatory approval to commence a clinical trial with stem cell

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.